In addition, integrin subunit beta 3 (ITGB3) was identified as a target to overcome chemoresistance in mesenchymal lung cancer, and inhibition of ITGB3 sensitizes cancer cells to chemotherapy by regulating the NF-κB pathway (13). The gene discussed is ITGB3; the disease is cancer.